Gevo Inc (NASDAQ: GEVO) stock jumped 6.03% on Friday to $1.23 against a previous-day closing price of $1.16. With 4.59 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.82 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $1.2400 whereas the lowest price it dropped to was $1.1400. The 52-week range on GEVO shows that it touched its highest point at $2.30 and its lowest point at $0.97 during that stretch. It currently has a 1-year price target of $4.52. Beta for the stock currently stands at 3.04.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GEVO was up-trending over the past week, with a rise of 11.82%, but this was up by 18.27% over a month. Three-month performance dropped to -15.75% while six-month performance rose 6.03%. The stock lost -47.21% in the past year, while it has lost -35.26% so far this year. A look at the trailing 12-month EPS for GEVO yields -0.31 with Next year EPS estimates of -0.27. For the next quarter, that number is -0.06. This implies an EPS growth rate of 23.96% for this year and -8.71% for next year. EPS is expected to grow by 25.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 57.03%.
Float and Shares Shorts:
At present, 237.17 million GEVO shares are outstanding with a float of 230.69 million shares on hand for trading. On Oct 30, 2023, short shares totaled 34.47 million, which was 14.52% higher than short shares on Sep 28, 2023. In addition to Dr. Patrick R. Gruber M.B.A., Ph.D. as the firm’s CEO & Director, Dr. Christopher M. Ryan serves as its President & COO.
Through their ownership of 45.69% of GEVO’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 4.54% of GEVO, in contrast to 24.64% held by mutual funds. Shares owned by individuals account for 16.95%. As the largest shareholder in GEVO with 8.71% of the stake, BlackRock Fund Advisors holds 20,675,456 shares worth 20,675,456. A second-largest stockholder of GEVO, SSgA Funds Management, Inc., holds 13,677,077 shares, controlling over 5.76% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in GEVO, holding 12,845,913 shares or 5.41% stake. With a 4.06% stake in GEVO, the SPDR S&P Oil & Gas Exploration & is the largest stakeholder. A total of 9,645,193 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.89% of GEVO stock, is the second-largest Mutual Fund holder. It holds 6,871,435 shares valued at 7.35 million. iShares Russell 2000 ETF holds 2.60% of the stake in GEVO, owning 6,165,751 shares worth 6.6 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GEVO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GEVO analysts setting a high price target of $14.00 and a low target of $1.50, the average target price over the next 12 months is $4.52. Based on these targets, GEVO could surge 1038.21% to reach the target high and rise by 21.95% to reach the target low. Reaching the average price target will result in a growth of 267.48% from current levels.
Summary of Insider Activity:
Insiders traded GEVO stock several times over the past three months with 0 Buys and 8 Sells. In these transactions, 0 shares were bought while 547,768 shares were sold. The number of buy transactions has increased to 13 while that of sell transactions has risen to 22 over the past year. The total number of shares bought during that period was 2,375,029 while 899,558 shares were sold.